Why the study?
Minoritized racial and ethnic groups experience higher heart failure morbidity and mortality and higher COVID-19 infection rates driven by social determinants of health.
The COVID-19 pandemic highlighted existing disparities in heart failure outcomes among minoritized groups driven by social determinants of health, presenting an opportunity to improve health equity.
May inform equity strategies in heart failure amid COVID-19; leaves open prospective trials of targeted interventions.
Minoritized racial and ethnic groups have the highest incidence, prevalence, and hospitalization rate for heart failure. Despite improvement in medical therapies and overall survival, the morbidity and mortality of these groups remain elevated. The reasons for this disparity are multifactorial, including social determinant of health (SDOH) such as access to care, bias, and structural racism. These same factors contributed to higher rates of COVID-19 infection among minoritized racial and ethnic groups. In this review, we aim to explore the lessons learned from the COVID-19 pandemic and its interconnection between heart failure and SDOH. The pandemic presents a window of opportunity for achieving greater equity in the health care of all vulnerable populations.
No takes yet. Share an insight, caveat, or question.
Contreras et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: